Pfizer and BioNTech’s clinical trial to evaluate their COVID-19 vaccine in pregnant women has been discontinued, according to a newly disclosed internal Pfizer email filed as evidence in a recent court case. The case in part challenges if the vaccine has been adequately tested to assess for risks to women’s reproductive health.
A professor of medicine at the University of Calgary sent an email on April 1 to Pfizer Canada inquiring about the status of their clinical trial, which was announced publicly in February 2021.
“I represent the Society of Obstetricians and Gynaecologists of Canada @ NACI [National Advisory Committee for Immunization],” professor Dr. Eliana Castillo wrote in the email, indicating she had two questions for Pfizer to “continue to support our providers and patients with our guidelines.”…